Nanobiomaterials and Nanomedicines for Metabolic Disorders

Know about the book -

Nanobiomaterials and Nanomedicines for Metabolic Disorders is written by Subhash C. Mandal and published by Elsevier. It's available with International Standard Book Number or ISBN identification 0443289425 (ISBN 10) and 9780443289422 (ISBN 13).

Nanobiomaterials and Nanomedicines for Metabolic Disorders explores the application of nanoparticles and nanotechnology for a range of metabolic pathways and disorders. Divided into five distinct sections, this book covers various aspects of nanomedicine, from the relevant nanoparticle classes and synthesis of biomaterial/drug delivery platforms to diagnostics and imaging, as well as therapeutic strategies. Later chapters address specific metabolic disorders, including lifestyle-related, cellular, and cardiovascular, highlighting the potential of engineered and targeted nanomedicines in modulating metabolic processes, alleviating symptoms, and providing improved patient outcomes. Nanobiomaterials and Nanomedicines for Metabolic Disorders caters to an interdisciplinary readership, appealing to researchers, students, and healthcare professionals with an interest in the development of novel theranostic approaches to metabolic disorders.